Pictet-Biotech I dy GBP (FUND:B554RF5) - Fund price

Fund Report

Pictet-Biotech I dy GBP

Name of CompanyPictet Asset Management (Europe) SA
Fund CompanyPictet
Phone+352 467 171-1
Address15, avenue J.F. Kennedy
Luxembourg L-1855
Legal StructureSICAV
Inception Date10/09/2009

Fund Advisor(s)

Pictet Asset Management S.A.
Fund ManagerLydia Haueter
Manager Start Date26/05/2016
Fund ManagerTazio Storni
Manager Start Date26/05/2016
Fund ManagerMarco Minonne
Manager Start Date01/06/2020
BiographyMarco Minonne, CFA, Senior Vice President, rejoined the firm in 2013. Marco is part of the Growth Equity Group which is responsible for Neuberger Berman’s Mid Cap Growth and Small Cap Growth strategies. He is an Associate Portfolio Manager on Small Cap Growth and a Research Analyst covering the health care sector on Mid Cap Growth. Prior to rejoining Neuberger Berman, Marco was a senior therapeutic analyst with Columbia Management. He has previously held research analyst positions at Citadel Investment Group, Neuberger Berman and Northern Trust Bank. Marco has extensive buy-side experience in health care and has been involved in both long-only and long-short strategies. Marco earned a Bachelor of Arts in Finance and Economics from the University of Iowa and has been awarded the Chartered Financial Analyst designation.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.